(Q38244838)

31 August 2017

Role of plasminogen activator inhibitor-1 in senescence and aging (English)

1 reference

31 August 2017

1 reference

Mesut Eren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

Amanda E Boe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

Ekaterina A Klyachko

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

Douglas E Vaughan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

publication date

31 August 2014

1 reference

Seminars in Thrombosis and Hemostasis

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

page(s)

645-651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

Plasmin and matrix metalloproteinases in vascular remodeling

15 May 2020

cites work

1 reference

12 December 2020

Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects

1 reference

12 December 2020

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

1 reference

12 December 2020

Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction

1 reference

12 December 2020

Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition

1 reference

12 December 2020

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

1 reference

12 December 2020

Aging accelerates endotoxin-induced thrombosis : increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging

1 reference

12 December 2020

Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse

1 reference

12 December 2020

Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression

1 reference

12 December 2020

Pharmacological modulation of the endotoxin-induced increase in plasminogen activator inhibitor activity in rats

1 reference

12 December 2020

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

12 December 2020

Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.

1 reference

12 December 2020

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors

1 reference

12 December 2020

Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator Inhibitor-1 through a JNK-mediated pathway

1 reference

12 December 2020

Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis

1 reference

12 December 2020

Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.

1 reference

12 December 2020

The power and the promise of oncogene-induced senescence markers.

1 reference

12 December 2020

Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence

1 reference

12 December 2020

PAI-1 and the metabolic syndrome: links, causes, and consequences

1 reference

12 December 2020

Senescence, wound healing and cancer: the PAI-1 connection

1 reference

12 December 2020

Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice.

1 reference

12 December 2020

Human visceral adipose tissue and the plasminogen activator inhibitor type 1

1 reference

12 December 2020

Cellular senescence: when bad things happen to good cells

1 reference

12 December 2020

DNA damage, cellular senescence and organismal ageing: causal or correlative?

1 reference

12 December 2020

A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

1 reference

12 December 2020

Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency

1 reference

12 December 2020

Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling

1 reference

12 December 2020

Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy

1 reference

12 December 2020

The Pro/Pro genotype of the p53 codon 72 polymorphism modulates PAI-1 plasma levels in ageing.

1 reference

12 December 2020

Plasminogen activator inhibitor-1 regulates myoendothelial junction formation

1 reference

12 December 2020

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

1 reference

12 December 2020

Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

1 reference

12 December 2020

Four faces of cellular senescence.

1 reference

12 December 2020

Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

1 reference

12 December 2020

A senescent cell bystander effect: senescence-induced senescence

1 reference

12 December 2020

A novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction

1 reference

12 December 2020

Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

1 reference

12 December 2020

Plasminogen activator inhibitor-1 (PAI-1) expression in relation to hypoxia and oncoproteins in clinical cervical tumors

1 reference

12 December 2020

SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence

1 reference

12 December 2020

Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence

1 reference

12 December 2020

1 reference

12 December 2020

Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves.

1 reference

12 December 2020

PAI-1-regulated extracellular proteolysis governs senescence and survival in Klotho mice.

1 reference

12 December 2020

Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age

1 reference

12 December 2020

Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations

1 reference

12 December 2020

Differential growth state-dependent regulation of plasminogen activator inhibitor type-1 expression in senescent IMR-90 human diploid fibroblasts

1 reference

12 December 2020

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

12 December 2020

Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells

1 reference

12 December 2020

The effect of ageing on platelet function and fibrinolytic activity

1 reference

12 December 2020

Plasminogen activator system in human coronary atherosclerosis

1 reference

12 December 2020

Plasminogen activator expression in human atherosclerotic lesions

1 reference

12 December 2020

Overexpression of plasminogen activator inhibitor type-1 in senescent fibroblasts from normal subjects and those with Werner syndrome

1 reference

12 December 2020

Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery diseases

1 reference

12 December 2020

1 reference

12 December 2020

Inhibitors of fibrinolysis are elevated in atherosclerotic plaque

1 reference

12 December 2020

Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence.

1 reference

12 December 2020

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

12 December 2020

PAI-1, obesity, insulin resistance and risk of cardiovascular events

1 reference

12 December 2020

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

1 reference

12 December 2020

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

1 reference

12 December 2020

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.

1 reference

12 December 2020

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

1 reference

12 December 2020

Identifiers

DOI

10.1055/S-0034-1387883

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6563930&resulttype=core&format=json

15 May 2020

1 reference